EGFR/CDK2-IN-2
EGFR/CDK2-IN-2 (compound 6a) is a dual inhibitor of EGFR and CDK-2 with IC50s of 19.6 and 87.9 nM, respectively. EGFR/CDK2-IN-2 induces apoptosis in MCF-7 cells and arrests the cell cycle in the S phase. EGFR/CDK2-IN-2 has significant anti-cancer cell toxicity and inhibits MCF-7 with an IC50 of 0.39 μM[1].
Product Specifications
UNSPSC
12352005
Target
CDK; EGFR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-cdk2-in-2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN(C2=CC=CC=C2)N=C1C3=NN4C(SC3)=NN=C4CC5=NN=C6SCC(C7=NN(C8=CC=CC=C8)C=C7C(C9=CC=C%10C=CC=CC%10=C9)=O)=NN65)C%11=CC=C%12C=CC=CC%12=C%11
Molecular Formula
C49H32N12O2S2
Molecular Weight
884.99
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tmem41a (NM_001100805) Rat Tagged ORF Clone Lentiviral Particle
C4orf18, ID (FAM198B, C4orf18, ENED, Protein FAM198B, Expressed in nerve and epithelium during development) (AP)
C4orf18, ID (FAM198B, C4orf18, ENED, Protein FAM198B, Expressed in nerve and epithelium during development) (AP)